EP1731182A1 - Perkutane Zugangsvorrichtung - Google Patents

Perkutane Zugangsvorrichtung Download PDF

Info

Publication number
EP1731182A1
EP1731182A1 EP06076669A EP06076669A EP1731182A1 EP 1731182 A1 EP1731182 A1 EP 1731182A1 EP 06076669 A EP06076669 A EP 06076669A EP 06076669 A EP06076669 A EP 06076669A EP 1731182 A1 EP1731182 A1 EP 1731182A1
Authority
EP
European Patent Office
Prior art keywords
sleeve
access device
percutaneous access
flange
catheter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP06076669A
Other languages
English (en)
French (fr)
Other versions
EP1731182B1 (de
Inventor
Rob Sommerich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Codman and Shurtleff Inc
Original Assignee
Codman and Shurtleff Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codman and Shurtleff Inc filed Critical Codman and Shurtleff Inc
Publication of EP1731182A1 publication Critical patent/EP1731182A1/de
Application granted granted Critical
Publication of EP1731182B1 publication Critical patent/EP1731182B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • A61M2039/025—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body through bones or teeth, e.g. through the skull
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • A61M2039/0273—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body for introducing catheters into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • A61M2039/0285—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body with sterilisation means, e.g. antibacterial coatings, disinfecting pads, UV radiation LEDs or heating means in the port

Definitions

  • the present invention relates to a percutaneous access device, and in particular to a percutaneous access device that is effective to prevent or reduce the risk of infection in tissue surrounding the percutaneous device.
  • Percutaneous access devices are used to introduce extracorporeal medical devices, such as catheters, through the skin for a variety of purposes, including to transport fluid, conduct diagnostic tests, access blood for dialysis, monitor pressure, and deliver drugs.
  • Hydrocephalus for example, can require the use of an external ventricular drainage (EVD) catheter to remove fluid from a patient's ventricle.
  • EMD external ventricular drainage
  • Hydrocephalus is a neurological condition that is caused by the abnormal accumulation of cerebrospinal fluid (CSF) within the ventricles, or cavities, of the brain.
  • CSF cerebrospinal fluid
  • CSF cerebrospinal fluid
  • Hydrocephalus which can affect people of any age, but affects mostly infants and young children, arises when the normal drainage of CSF in the brain is blocked in some way. Blockage of the flow of CSF requires an increasing pressure for CSF to be absorbed into the bloodstream. This increasing pressure can interfere with the perfusion of the nervous system. Hydrocephalus can be treated by introducing an EVD catheter through a burr hole in a patient's skull and implanting the catheter in the patient's ventricle.
  • EVD catheters One common risk associated with the use of many catheters, including ventricular catheters, is the risk of infection at the site of the catheter insertion.
  • Current reported infection rates of EVD catheters range from 1-25%, with the typical rate of approximately 17%.
  • Minimizing or eliminating the risk of infection is critical for devices that contact the brain or cerebrospinal fluid.
  • Current efforts to approach this issue include coating or impregnating the catheter with antibiotics or hydrophilic solutions that do not allow the bacteria to colonize on the surface of the device.
  • the present invention provides a percutaneous access device including a tubular sleeve having an inner lumen extending therethrough that is adapted to slidably receive a catheter, and at least one flange disposed around the sleeve and adapted to be positioned adjacent a tissue surface. At least one of the sleeve and the flange(s) include an antimicrobial agent.
  • the device includes a first flange disposed around the sleeve and adapted to be positioned adjacent a first tissue surface, and a second flange disposed around the sleeve and spaced apart from the first flange such that the second flange is adapted to be disposed adjacent a second tissue surface opposed to the first tissue surface.
  • the second flange is preferably positioned at a distal end of the sleeve, and the first flange is preferably positioned a distance apart from a proximal end of the sleeve to allow a proximal end of the sleeve to be grasped during use.
  • the first and second flanges can extend in a direction substantially transverse to an axis of the sleeve.
  • the sleeve is adapted to slidably and sealingly receive a catheter.
  • the percutaneous access device is used with a ventricular catheter.
  • a catheter kit including a percutaneous access device having a body with a lumen extending therethrough and adapted to receive a catheter, and at least one tissue-protecting member adapted to protect tissue surrounding the percutaneous access device from coming into contact with a catheter.
  • the percutaneous access device also includes an antimicrobial agent.
  • the kit further includes a catheter adapted to be slidably and sealingly disposed through the lumen in the percutaneous access device.
  • the present invention generally provides a percutaneous access device 10 that is effective for use in inserting a percutaneous device, such as a catheter 50, into a patient. While the device is described and illustrated for use with a ventricular catheter, a person skilled in the art will appreciate that the device can be used for a variety of procedures and with a variety of percutaneous devices, including, for example, urethral, venous, and arterial catheters, orthopaedic trauma pins, intracranial press sensors, and other percutaneous device, including both short-term and long-term devices.
  • the device 10 includes a sleeve 12 having an inner lumen 14 extending therethrough for receiving a catheter 50, and at least one tissue-protecting member disposed around the sleeve 12.
  • the device 10 includes first and second tissue-protecting members that are in the form of first and second flanges 16, 18 positioned around the sleeve 12 and spaced a distance apart from one another.
  • the flanges 16, 18 are positioned on opposed sides of tissue 40 so that the device 10 is effective to prevent tissue surrounding the percutaneous access device from coming into contact with the catheter inserted through the sleeve 12.
  • the device 10 also includes an antimicrobial agent that is effective to protect against bacterial colonization on and around the access device 10, the catheter 50, and the tissue 40 surrounding the access device 10.
  • the sleeve 12 can have a variety of shapes and sizes, but should be adapted to receive a catheter 50 or a similar percutaneous delivery or fluid withdrawal device. As shown in FIGS. 1 and 2, the sleeve 12 is substantially cylindrical and includes a proximal end 12a, a distal end 12b, and an inner lumen 14 extending therethrough. The inner lumen 14 of the sleeve 12 is preferably adapted to sealingly, yet slidably receive a catheter 50 therein. The sealing effect can be achieved using a variety of techniques. By way of non limiting example , the sleeve 12 can have an inner diameter substantially the same as or slightly smaller than a diameter of the catheter 50 adapted to be disposed therein.
  • the sleeve 12 can be formed from a pliable material to allow the sleeve 12 to expand during insertion of the catheter, while providing a fluid-tight seal around a catheter.
  • the sleeve 12 can optionally include a longitudinal slit (not shown) to facilitate placement of the catheter 50, or other device, within the sleeve 12. Once the catheter or other device is placed within the sleeve 12, the sleeve would preferably self-close around the catheter to form a tight seal.
  • an expander tool (not shown) can optionally be used to facilitate insertion of the catheter 50 into the sleeve.
  • the expander tool can have virtually any configuration, but should be effective to stretch or expand the inner diameter of the sleeve 12 to allow for insertion of the catheter 50.
  • the inner diameter of the sleeve 12 is in the range of about 0.25-10 mm.
  • the inner diameter of sleeve can vary based on the intended use.
  • the sleeve 12 is not limited to having a cylindrical shape, but rather can be adapted for use with other devices having a variety of shapes and sizes.
  • the inner lumen 14 of the sleeve 12 can include a seal disposed therein.
  • the seal can be a sheath, web, mesh, or similar type of material disposed around all or a portion of the inner surface of the sleeve 12.
  • the seal can be an annular ring or valve-type member that is preferably disposed adjacent the proximal and distal ends 12a, 12b.
  • the tissue-protecting member(s) 16, 18 also have a variety of configurations, but are preferably disposed around the sleeve 12 and effective to protect the tissue surface surrounding the device 10 from coming into contact with a catheter that is inserted through or disposed within the sleeve 12.
  • the tissue-protecting member can have, virtually any shape and size, and can be positioned anywhere along the sleeve 12.
  • the device 10 includes first and second tissue-protecting members positioned a distance apart from one another to allow tissue 40 to be disposed therebetween. As shown in FIGS. 1 and 2, the tissue-protecting members are in the form of first and second flanges 16, 18 disposed around the sleeve 12 and positioned a distance d l apart from one another.
  • the first and second flanges 16, 18 can be formed as a unitary construction with the sleeve 12, or one or both of the flanges 16, 18 can be slidably disposed around the sleeve 12 to allow the distance d l between the flanges 16, 18 to be adjusted as desired.
  • the second flange 18 is fixedly positioned at the distal end 12b of the sleeve 12, and the first flange 16 is slidably positioned around the sleeve 12 at a distance from the proximal end 12a of the sleeve 12.
  • the position of the first flange 16 provides a proximal extension portion 12c of the sleeve 12 that can be grasped during use.
  • proximal extension portion 12c can be adapted to facilitate grasping and manipulation of the device 10, and thus can include a knurled surface, a handle, or similar features formed thereon or matable thereto.
  • FIGS. 1 and 2 illustrate substantially cylindrical flanges 16, 18 having a height h and diameter d f , which can vary depending on the intended use.
  • the diameter d f , of each flange 16, 18 is sufficient to allow the flanges 16, 18 to cover a surface area of tissue 40 surrounding the device 10 in order to prevent contact between a catheter 50 inserted through the sleeve 12 and the tissue surface 40.
  • the height h of each flange 16, 18 can also vary, but the height h should be sufficient to provide some flexibility, at least to the second flange 18, to allow the device 10 to be implanted through a slit in formed in the tissue, as will be discussed in more detail below.
  • the tissue-protecting members can have any shape and size, and that the illustrated flanges 16,18 are merely exemplary embodiments of one type of a tissue-protecting member.
  • At least one of the flanges 16, 18 can also include one or more anchor members (not shown) formed thereon or mated thereto for attaching the flange(s) 16, 18 to the tissue surface.
  • the anchor members can be formed on or mated to any portion of the flange(s) 16, 18, and can have a variety of configurations.
  • each anchor member is disposed around a periphery of the flange(s) 16, 18.
  • a variety of anchor members can be used including, for example, eyelets,hooks,adhesives,and combinations thereof. In use, each anchor member can be sutured or otherwise attached to the tissue surface to securely attach the device 10 to the tissue surface.
  • Each component 12, 16, 18 of the device 10 can also be made from a variety of materials, but preferably at least a portion of the device 10 includes an antimicrobial agent.
  • the agent can be coated onto, implanted within, or impregnated within the device 10 using a variety of techniques.
  • the sleeve 12 and the first and second flanges 16, 18 are formed from a material capable of being impregnated with an antimicrobial agent.
  • U.S. Patent No. 4,917,686 of Bayston et al. which is incorporated herein by reference in its entirety, discloses an antimicrobial medical implant device that exhibits persistent antimicrobial activity, and methods for making the same.
  • an antimicrobial agent can be embedded within the percutaneous access device of the invention by subjecting all surfaces of the body of the device (which is made of a polymeric material) to a solution containing (1) a suitable swelling agent (solvent), such as hexane, toluene, xylene or preferably chloroform, and (2) an antimicrobial agent(s) (solute).
  • a suitable swelling agent such as hexane, toluene, xylene or preferably chloroform
  • an antimicrobial agent(s) solute.
  • the swelling agent is effective to increase the intermolecular spaces of the polymer, thereby allowing the solution to penetrate and swell the entire body of polymeric material.
  • the antimicrobial is dispersed throughout the body of the device within the enlarged intermolecular spaces thereof.
  • the swelling agent is thereafter removed by evaporation to reverse swelling, while allowing the antimicrobial agent(s) to be retained in a substantially uniform dispersion in the intermolecular spaces throughout the body of polymeric material.
  • the molecules of the antimicrobial agent(s) are thus essentially in a solid state solution with the molecules of the body of the polymeric material, and will thereafter migrate toward the surfaces of the device and through the surfaces thereof solely by molecular diffusion.
  • the device is suitably sterilized by appropriate known techniques. Typical sterilization methods used for medical devices can be used for the antimicrobial sheath including, for example, steam sterilization.
  • the antimicrobial agent(s) within the body of polymeric material are released to and through the surfaces by solid state diffusion. Because of the molecular structure of the polymer and the intimate molecular association of the antimicrobial agent(s) therewith, the diffusion of these agent(s) occurs at a rate which provides antimicrobial efficacy at the surfaces of the device for a substantial period of time.
  • surgically implanted silicone elastomer percutaneous access devices when processed according to the invention, will resist bacterial contamination introduced at the time of surgery which can lead to the colonization of the implant and its ultimate failure, removal and replacement; and will provide longer period of protection against colonization by introduced bacteria due to the constant diffusion of antimicrobial to the surfaces of the device.
  • the sleeve 12 and the flanges 16, 18 can include a cavity formed therein for receiving an antimicrobial agent, as disclosed in U.S. Patent No. 5,820,607 of Tcholakian et al. ("Tcholakian”), which is also incorporated herein by reference in its entirety.
  • Tcholakian Tcholakian et al.
  • antimicrobial agents can be included with the percutaneous access device of the invention.
  • Exemplary antimicrobial agents for use in making a percutaneous access device in accordance with the present invention include the following: (1) rifampin, which is a semisynthetic antibiotic derivative of rifamycin B (specifically, rifampin is the hydrazone, 3-(4-methyl-1-piperazinyliminomethyl)-rifampinSV.); and (2) clindamycin hydrochloride.
  • the exemplary antimicrobial agents can be used in combination as a solute, which is commercially available under the name BACTISEAL TM , manufactured by Codman & Shurtleff, Inc. of Raynham, Massachusetts.
  • antibiotics include antibiotics, antifungal, and antiviral agents.
  • Suitable antibiotics include, for example, minocycline, rifampin, penicillins, cephaloporins, monobactams, carbapenems, clindamycin, chloramphenicol, tetracycline, quinolones, macrolides, sulfa antibiotics, trimethoprim, fusidic acid and aminoglycosides.
  • Suitable antiviral agents include, for example, acyclovir, ganciclovir, fosiornet and pencyclovir, and suitable antifungal agents include, for example, amphotericin B, azoles, flucytosine, cilofungin and nikko Z.
  • the percutaneous access device can also optionally include anticoagulants, antifibrin agents, anti-inflammatory agents, and other useful agents not specifically disclosed herein.
  • Suitable anticoagulants include, for example, EGTA, EDTA, heparin, urokinase, streptokinase, and others, and suitable anti-inflammatory agents include steroids, nonsteroidal antiinflammatory agents, and salicylates.
  • the effective amount of antimicrobial agent(s) employed is dependent upon the size and shape of the particular medical device and upon the kind and wall thicknesses of the selected polymeric material. In the presently preferred embodiments, the amount of antimicrobial agent(s) is preferably about 0.1% to 1.0%, and more preferably is about 0.1 % to 0.2%, by weight of each agent to volume of solvent.
  • FIGS. 3-4 illustrate the device 10 in use.
  • the device 10 can be used to introduce a variety of percutaneous devices into a patient's body, but in an exemplary embodiment the device 10 is used to introduce a ventricular catheter 50 through a patient's skull to enable the catheter 50 to be inserted into the patient's ventricles.
  • an incision 60 is made in the tissue 40 on the patient's skull.
  • the second flange 18 on the access device 10 is then inserted through the slit to position the second flange 18 underneath and adjacent to the tissue surface, as shown in FIG. 2.
  • the proximal portion 12c of the sleeve 12 can be grasped while the first flange 16 is slid toward the second flange 18 and positioned against the opposed tissue surface to sandwich the tissue 40 between the flanges 16, 18.
  • a catheter 50 can then be inserted through the inner lumen 14 in the sleeve 12 to position the catheter 50 as desired.
  • an expander tool can be utilized to stretch the sleeve 12 to allow insertion of the catheter 50 therethrough. Once the expander tool is released, the sleeve 12 returns to its original size, whereby the sleeve 12 provides a fluid-tight seal around the catheter 50. The catheter 50 can then be slid with respect to the device 10, as necessary.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Materials For Medical Uses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP06076669A 2003-05-30 2004-05-28 Perkutane Zugangsvorrichtung Expired - Lifetime EP1731182B1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/449,179 US6916310B2 (en) 2003-05-30 2003-05-30 Percutaneous access device
EP04253209A EP1481697B8 (de) 2003-05-30 2004-05-28 Perkutane Zugangsvorrichtung

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
EP04253209A Division EP1481697B8 (de) 2003-05-30 2004-05-28 Perkutane Zugangsvorrichtung
EP04253209.3 Division 2004-05-28

Publications (2)

Publication Number Publication Date
EP1731182A1 true EP1731182A1 (de) 2006-12-13
EP1731182B1 EP1731182B1 (de) 2012-09-26

Family

ID=33131630

Family Applications (2)

Application Number Title Priority Date Filing Date
EP04253209A Expired - Lifetime EP1481697B8 (de) 2003-05-30 2004-05-28 Perkutane Zugangsvorrichtung
EP06076669A Expired - Lifetime EP1731182B1 (de) 2003-05-30 2004-05-28 Perkutane Zugangsvorrichtung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP04253209A Expired - Lifetime EP1481697B8 (de) 2003-05-30 2004-05-28 Perkutane Zugangsvorrichtung

Country Status (6)

Country Link
US (2) US6916310B2 (de)
EP (2) EP1481697B8 (de)
JP (1) JP4767503B2 (de)
AT (1) ATE354384T1 (de)
DE (1) DE602004004834T2 (de)
ES (2) ES2394646T3 (de)

Families Citing this family (164)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60142978D1 (de) 2000-10-19 2010-10-14 Applied Med Resources Chirurgisches zugangsgerät und -verfahren
EP2422829B1 (de) 2001-08-14 2013-03-06 Applied Medical Resources Corporation Gerät zum Verschliessen von chirurgischen Zugängen
US6958037B2 (en) 2001-10-20 2005-10-25 Applied Medical Resources Corporation Wound retraction apparatus and method
EP2340792B1 (de) 2002-06-05 2012-05-09 Applied Medical Resources Corporation Wundspreizer
US20050020884A1 (en) 2003-02-25 2005-01-27 Hart Charles C. Surgical access system
US7731697B2 (en) * 2003-04-12 2010-06-08 Incumed Llc, A Nevada Limited Liability Co. Apparatus and method for percutaneous catheter implantation and replacement
US7811274B2 (en) 2003-05-07 2010-10-12 Portaero, Inc. Method for treating chronic obstructive pulmonary disease
US7426929B2 (en) 2003-05-20 2008-09-23 Portaero, Inc. Intra/extra-thoracic collateral ventilation bypass system and method
US7252086B2 (en) 2003-06-03 2007-08-07 Cordis Corporation Lung reduction system
US7377278B2 (en) 2003-06-05 2008-05-27 Portaero, Inc. Intra-thoracic collateral ventilation bypass system and method
US7682332B2 (en) 2003-07-15 2010-03-23 Portaero, Inc. Methods to accelerate wound healing in thoracic anastomosis applications
WO2005013803A2 (en) 2003-08-06 2005-02-17 Applied Medical Resources Corporation Surgical device with tack-free gel and method of manufacture
US7163510B2 (en) 2003-09-17 2007-01-16 Applied Medical Resources Corporation Surgical instrument access device
US7585290B2 (en) * 2004-01-20 2009-09-08 Ethicon Endo-Surgery, Inc. Medical device for providing access
GB0421164D0 (en) 2004-09-23 2004-10-27 Univ Nottingham Medical devices and methods of making medical devices
US20060079845A1 (en) * 2004-10-08 2006-04-13 Eben Howard And Pamela A. Howard Movable inflatable anchor for medical devices
US20060079838A1 (en) * 2004-10-08 2006-04-13 Walker Steven C Movable Balloon anchor for medical devices
US8220460B2 (en) 2004-11-19 2012-07-17 Portaero, Inc. Evacuation device and method for creating a localized pleurodesis
US7824366B2 (en) 2004-12-10 2010-11-02 Portaero, Inc. Collateral ventilation device with chest tube/evacuation features and method
WO2007002185A2 (en) 2005-06-21 2007-01-04 Cardiomems, Inc. Method of manufacturing implantable wireless sensor for in vivo pressure measurement
US8104474B2 (en) 2005-08-23 2012-01-31 Portaero, Inc. Collateral ventilation bypass system with retention features
CA2625734C (en) 2005-10-14 2013-02-19 Applied Medical Resources Corporation Method of making a hand access laparoscopic device
US7406963B2 (en) 2006-01-17 2008-08-05 Portaero, Inc. Variable resistance pulmonary ventilation bypass valve and method
US20070260273A1 (en) * 2006-05-08 2007-11-08 Ethicon Endo-Surgery, Inc. Endoscopic Translumenal Surgical Systems
US7963912B2 (en) * 2006-05-08 2011-06-21 Ethicon Endo-Surgery, Inc. Endoscopic translumenal surgical methods using a sheath
US20070260121A1 (en) * 2006-05-08 2007-11-08 Ethicon Endo-Surgery, Inc. Endoscopic Translumenal Surgical Systems
US8021340B2 (en) * 2006-07-05 2011-09-20 Incumed, Llc Enhanced apparatus for percutaneous catheter implantation and replacement
GB0623395D0 (en) 2006-11-23 2007-01-03 Renishaw Plc Port
US8894582B2 (en) 2007-01-26 2014-11-25 Endotronix, Inc. Cardiac pressure monitoring device
US8493187B2 (en) 2007-03-15 2013-07-23 Endotronix, Inc. Wireless sensor reader
US8154389B2 (en) 2007-03-15 2012-04-10 Endotronix, Inc. Wireless sensor reader
US10003862B2 (en) 2007-03-15 2018-06-19 Endotronix, Inc. Wireless sensor reader
WO2008115456A1 (en) * 2007-03-15 2008-09-25 Nunez Anthony I Transseptal monitoring device
US8570186B2 (en) 2011-04-25 2013-10-29 Endotronix, Inc. Wireless sensor reader
US8597253B2 (en) 2007-04-20 2013-12-03 Bard Access Systems Huber needle with safety sheath
US7931641B2 (en) 2007-05-11 2011-04-26 Portaero, Inc. Visceral pleura ring connector
EP2146644A4 (de) 2007-05-11 2012-07-18 Applied Med Resources Chirurgischer retraktor
US8163034B2 (en) 2007-05-11 2012-04-24 Portaero, Inc. Methods and devices to create a chemically and/or mechanically localized pleurodesis
WO2008141291A1 (en) 2007-05-11 2008-11-20 Applied Medical Resources Corporation Surgical retractor with gel pad
US8062315B2 (en) 2007-05-17 2011-11-22 Portaero, Inc. Variable parietal/visceral pleural coupling
US8177753B2 (en) * 2007-06-01 2012-05-15 Arrow International, Inc. Catheter insertion assembly
US20090043314A1 (en) * 2007-07-16 2009-02-12 The Cleveland Clinic Foundation Access device for body tissue and method of using same
KR101511497B1 (ko) 2007-10-05 2015-04-13 코비디엔 엘피 수술 절차에 사용하기 위한 밀봉부 고정구
US20090093683A1 (en) * 2007-10-05 2009-04-09 Tyco Healthcare Group Lp Surgical portal kit for use in single incision surgery
US20100100043A1 (en) * 2007-10-05 2010-04-22 Racenet Danyel J Flexible Access Device For Use In Surgical Procedure
EP2203139A4 (de) * 2007-10-12 2010-12-01 Medical Res Products B Inc Medizinisches gerät und verfahren zur erleichterung der kontrolle von langfristigen tunnelierten leitungen
CA2711116C (en) 2008-01-22 2017-08-29 Applied Medical Resources Corporation Surgical instrument access device
US8336540B2 (en) 2008-02-19 2012-12-25 Portaero, Inc. Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease
US8475389B2 (en) 2008-02-19 2013-07-02 Portaero, Inc. Methods and devices for assessment of pneumostoma function
WO2009105432A2 (en) 2008-02-19 2009-08-27 Portaero, Inc. Devices and methods for delivery of a therapeutic agent through a pneumostoma
US10245098B2 (en) 2008-04-29 2019-04-02 Virginia Tech Intellectual Properties, Inc. Acute blood-brain barrier disruption using electrical energy based therapy
US8992517B2 (en) 2008-04-29 2015-03-31 Virginia Tech Intellectual Properties Inc. Irreversible electroporation to treat aberrant cell masses
US9198733B2 (en) 2008-04-29 2015-12-01 Virginia Tech Intellectual Properties, Inc. Treatment planning for electroporation-based therapies
US10272178B2 (en) 2008-04-29 2019-04-30 Virginia Tech Intellectual Properties Inc. Methods for blood-brain barrier disruption using electrical energy
US11254926B2 (en) 2008-04-29 2022-02-22 Virginia Tech Intellectual Properties, Inc. Devices and methods for high frequency electroporation
US9283051B2 (en) 2008-04-29 2016-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating a treatment volume for administering electrical-energy based therapies
US9867652B2 (en) 2008-04-29 2018-01-16 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
US10117707B2 (en) 2008-04-29 2018-11-06 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US11272979B2 (en) 2008-04-29 2022-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US10702326B2 (en) 2011-07-15 2020-07-07 Virginia Tech Intellectual Properties, Inc. Device and method for electroporation based treatment of stenosis of a tubular body part
AU2009243079A1 (en) 2008-04-29 2009-11-05 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation to create tissue scaffolds
US10238447B2 (en) 2008-04-29 2019-03-26 Virginia Tech Intellectual Properties, Inc. System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
US8795161B2 (en) 2008-06-25 2014-08-05 Covidien Lp Button port
US7850667B2 (en) * 2008-06-27 2010-12-14 Tyco Healthcare Group Lp Low profile instrument access device
US9283632B2 (en) 2008-07-08 2016-03-15 Amada Company, Limited Tapping machine and tap die, and method of detecting overstroke of tap
USD738500S1 (en) 2008-10-02 2015-09-08 Covidien Lp Seal anchor for use in surgical procedures
CA2739910C (en) 2008-10-13 2017-06-06 Applied Medical Resources Corporation Single port access system
US8347881B2 (en) 2009-01-08 2013-01-08 Portaero, Inc. Pneumostoma management device with integrated patency sensor and method
US8518053B2 (en) 2009-02-11 2013-08-27 Portaero, Inc. Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US8317690B2 (en) * 2009-03-31 2012-11-27 Covidien Lp Foam port and introducer assembly
US8323184B2 (en) 2009-03-31 2012-12-04 Covidien Lp Surgical access port and associated introducer mechanism
US11638603B2 (en) 2009-04-09 2023-05-02 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
US11382681B2 (en) 2009-04-09 2022-07-12 Virginia Tech Intellectual Properties, Inc. Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
US9078712B2 (en) 2009-04-15 2015-07-14 Warsaw Orthopedic, Inc. Preformed drug-eluting device to be affixed to an anterior spinal plate
US8903488B2 (en) 2009-05-28 2014-12-02 Angiodynamics, Inc. System and method for synchronizing energy delivery to the cardiac rhythm
US9895189B2 (en) 2009-06-19 2018-02-20 Angiodynamics, Inc. Methods of sterilization and treating infection using irreversible electroporation
US20110021877A1 (en) * 2009-07-24 2011-01-27 Tyco Healthcare Group Lp Surgical port and frangible introducer assembly
US8257252B2 (en) 2009-08-06 2012-09-04 Tyco Healthcare Group Lp Elongated seal anchor for use in surgical procedures
US20110054258A1 (en) * 2009-08-31 2011-03-03 O'keefe Jonathan B Foam port introducer
US8932212B2 (en) 2009-10-01 2015-01-13 Covidien Lp Seal anchor with non-parallel lumens
US20110118553A1 (en) * 2009-11-19 2011-05-19 Tyco Healthcare Group Lp Access device including an integrated light source
US8480683B2 (en) 2009-11-24 2013-07-09 Covidien Lp Foam introduction system including modified port geometry
US8740904B2 (en) 2009-11-24 2014-06-03 Covidien Lp Seal anchor introducer including biasing member
US8343106B2 (en) 2009-12-23 2013-01-01 Alcon Research, Ltd. Ophthalmic valved trocar vent
PL2515774T3 (pl) 2009-12-23 2014-08-29 Alcon Res Ltd Okulistyczna kaniula trokara z zaworem
US20110166423A1 (en) * 2010-01-07 2011-07-07 Tyco Healthcare Group Lp Foam port introduction system including dilator
GB201002370D0 (en) 2010-02-12 2010-03-31 Renishaw Ireland Ltd Percutaneous drug delivery apparatus
US8425455B2 (en) 2010-03-30 2013-04-23 Angiodynamics, Inc. Bronchial catheter and method of use
FR2958170B1 (fr) * 2010-04-02 2013-07-26 Perouse Medical Necessaire d'injection d'un liquide dans un patient, comprenant une composition antimicrobienne.
US9421032B2 (en) * 2010-06-16 2016-08-23 Covidien Lp Seal port with blood collector
WO2012027386A2 (en) * 2010-08-23 2012-03-01 Imtec Biomedical Inc. A method and system of devices for permanent access to the circulatory system for chronic hemodialysis
US9248234B2 (en) 2010-09-10 2016-02-02 C. R. Bard, Inc. Systems for isolation of a needle-based infusion set
US10525234B2 (en) 2010-09-10 2020-01-07 C. R. Bard, Inc. Antimicrobial/haemostatic interface pad for placement between percutaneously placed medical device and patient skin
US20140066894A1 (en) 2010-09-10 2014-03-06 C. R. Bard, Inc. Self-Sealing Pad for a Needle-Based Infusion Set
US9289115B2 (en) 2010-10-01 2016-03-22 Applied Medical Resources Corporation Natural orifice surgery system
EP2621348B1 (de) 2010-10-01 2019-06-12 Applied Medical Resources Corporation Chirurgisches system für eine natürliche öffnung
US9700368B2 (en) 2010-10-13 2017-07-11 Angiodynamics, Inc. System and method for electrically ablating tissue of a patient
US8864659B2 (en) 2010-11-23 2014-10-21 Covidien Lp Seal anchor for use in surgical procedures
WO2012088149A2 (en) 2010-12-20 2012-06-28 Virginia Tech Intellectual Properties, Inc. High-frequency electroporation for cancer therapy
US20120157782A1 (en) 2010-12-20 2012-06-21 Francesco Alfieri Hand access device
US8550992B2 (en) 2010-12-20 2013-10-08 Covidien Lp Two-part access assembly
US8753267B2 (en) 2011-01-24 2014-06-17 Covidien Lp Access assembly insertion device
EP3461423B1 (de) 2011-05-10 2020-07-08 Applied Medical Resources Corporation Wundspreizer
US9078665B2 (en) 2011-09-28 2015-07-14 Angiodynamics, Inc. Multiple treatment zone ablation probe
US9271639B2 (en) 2012-02-29 2016-03-01 Covidien Lp Surgical introducer and access port assembly
CN104507515A (zh) * 2012-03-06 2015-04-08 Pfm医疗设备有限责任公司 抗菌插管器及针头
EP3632303B1 (de) 2012-09-14 2022-02-02 Endotronix, Inc. Drucksensor, anker, abgabesystem und verfahren
GB201217606D0 (en) * 2012-10-02 2012-11-14 Renishaw Plc Neurosurgical device and method
CA2892850C (en) * 2012-11-30 2018-12-11 Donald GRIFFITH Tissue bonding implantation device and method
WO2014143656A1 (en) 2013-03-15 2014-09-18 Applied Medical Resources Corporation Mechanical gel surgical access device
EP2968730B1 (de) 2013-03-15 2019-01-09 Bitol Designs, LLC Okklusionsresistenter katheter und verfahren zur verwendung
EP3027258B1 (de) * 2013-08-02 2020-04-22 Withers, Teresa Kathryn Katheterpositionierungsvorrichtung
US10471254B2 (en) 2014-05-12 2019-11-12 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
US10064649B2 (en) 2014-07-07 2018-09-04 Covidien Lp Pleated seal for surgical hand or instrument access
US9642608B2 (en) 2014-07-18 2017-05-09 Applied Medical Resources Corporation Gels having permanent tack free coatings and method of manufacture
WO2016025791A1 (en) 2014-08-15 2016-02-18 Applied Medical Resources Corporation Natural orifice surgery system
US9707011B2 (en) 2014-11-12 2017-07-18 Covidien Lp Attachments for use with a surgical access device
AU2015353660A1 (en) 2014-11-25 2017-05-18 Applied Medical Resources Corporation Circumferential wound retraction with support and guidance structures
WO2016100325A1 (en) 2014-12-15 2016-06-23 Virginia Tech Intellectual Properties, Inc. Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
RU2718620C2 (ru) * 2015-02-16 2020-04-10 Гуаладиспенсинг С.П.А. Транскраниальное крепежное устройство для дренажных катетеров
WO2016183145A1 (en) * 2015-05-11 2016-11-17 Access For Life, Inc. Vascular access device
US9996712B2 (en) 2015-09-02 2018-06-12 Endotronix, Inc. Self test device and method for wireless sensor reader
ES2836282T3 (es) 2015-09-15 2021-06-24 Applied Med Resources Sistema de acceso robótico quirúrgico
US20200238052A1 (en) * 2015-10-02 2020-07-30 Rabie Stephan Catheter port
ES2951168T3 (es) 2015-10-07 2023-10-18 Applied Med Resources Retractor de heridas con anillo exterior multisegmento
WO2018048948A1 (en) 2016-09-12 2018-03-15 Applied Medical Resources Corporation Surgical robotic access system for irregularly shaped robotic actuators and associated robotic surgical instruments
US10905492B2 (en) 2016-11-17 2021-02-02 Angiodynamics, Inc. Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
KR101996121B1 (ko) * 2016-12-05 2019-07-03 인제대학교 산학협력단 뇌척수액 운송용 도관의 이탈 방지 장치
US11615257B2 (en) 2017-02-24 2023-03-28 Endotronix, Inc. Method for communicating with implant devices
AU2018224198B2 (en) 2017-02-24 2023-06-29 Endotronix, Inc. Wireless sensor reader assembly
AU2018254569B2 (en) 2017-04-20 2022-05-12 Endotronix, Inc. Anchoring system for a catheter delivered device
US11160682B2 (en) 2017-06-19 2021-11-02 Covidien Lp Method and apparatus for accessing matter disposed within an internal body vessel
AU2018304316A1 (en) 2017-07-19 2020-01-30 Endotronix, Inc. Physiological monitoring system
US10828065B2 (en) 2017-08-28 2020-11-10 Covidien Lp Surgical access system
WO2019046837A1 (en) 2017-09-02 2019-03-07 Precision Drone Services Intellectual Property, Llc SEED DISTRIBUTION ASSEMBLY FOR AERIAL VEHICLE
US10675056B2 (en) 2017-09-07 2020-06-09 Covidien Lp Access apparatus with integrated fluid connector and control valve
US11607537B2 (en) 2017-12-05 2023-03-21 Virginia Tech Intellectual Properties, Inc. Method for treating neurological disorders, including tumors, with electroporation
US11311329B2 (en) 2018-03-13 2022-04-26 Virginia Tech Intellectual Properties, Inc. Treatment planning for immunotherapy based treatments using non-thermal ablation techniques
US11925405B2 (en) 2018-03-13 2024-03-12 Virginia Tech Intellectual Properties, Inc. Treatment planning system for immunotherapy enhancement via non-thermal ablation
US11389193B2 (en) 2018-10-02 2022-07-19 Covidien Lp Surgical access device with fascial closure system
US11457949B2 (en) 2018-10-12 2022-10-04 Covidien Lp Surgical access device and seal guard for use therewith
WO2020102498A1 (en) * 2018-11-14 2020-05-22 Cardiac Assist Holdings Llc Chain mail surgical collar and method of percutaneous device stabilization therewith
US11166748B2 (en) 2019-02-11 2021-11-09 Covidien Lp Seal assemblies for surgical access assemblies
US10792071B2 (en) 2019-02-11 2020-10-06 Covidien Lp Seals for surgical access assemblies
US11000313B2 (en) 2019-04-25 2021-05-11 Covidien Lp Seals for surgical access devices
US11413068B2 (en) 2019-05-09 2022-08-16 Covidien Lp Seal assemblies for surgical access assemblies
US11357542B2 (en) 2019-06-21 2022-06-14 Covidien Lp Valve assembly and retainer for surgical access assembly
US11259841B2 (en) 2019-06-21 2022-03-01 Covidien Lp Seal assemblies for surgical access assemblies
US11259840B2 (en) 2019-06-21 2022-03-01 Covidien Lp Valve assemblies for surgical access assemblies
US11950835B2 (en) 2019-06-28 2024-04-09 Virginia Tech Intellectual Properties, Inc. Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy
US11413065B2 (en) 2019-06-28 2022-08-16 Covidien Lp Seal assemblies for surgical access assemblies
US11399865B2 (en) 2019-08-02 2022-08-02 Covidien Lp Seal assemblies for surgical access assemblies
US11523842B2 (en) 2019-09-09 2022-12-13 Covidien Lp Reusable surgical port with disposable seal assembly
US11432843B2 (en) 2019-09-09 2022-09-06 Covidien Lp Centering mechanisms for a surgical access assembly
US11812991B2 (en) 2019-10-18 2023-11-14 Covidien Lp Seal assemblies for surgical access assemblies
US11464540B2 (en) 2020-01-17 2022-10-11 Covidien Lp Surgical access device with fixation mechanism
US11576701B2 (en) 2020-03-05 2023-02-14 Covidien Lp Surgical access assembly having a pump
US11642153B2 (en) 2020-03-19 2023-05-09 Covidien Lp Instrument seal for surgical access assembly
US11541218B2 (en) 2020-03-20 2023-01-03 Covidien Lp Seal assembly for a surgical access assembly and method of manufacturing the same
US11446058B2 (en) 2020-03-27 2022-09-20 Covidien Lp Fixture device for folding a seal member
US11717321B2 (en) 2020-04-24 2023-08-08 Covidien Lp Access assembly with retention mechanism
US11529170B2 (en) 2020-04-29 2022-12-20 Covidien Lp Expandable surgical access port
US11622790B2 (en) 2020-05-21 2023-04-11 Covidien Lp Obturators for surgical access assemblies and methods of assembly thereof
US11751908B2 (en) 2020-06-19 2023-09-12 Covidien Lp Seal assembly for surgical access assemblies

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0134340A1 (de) * 1983-08-22 1985-03-20 The University of Utah Research Foundation Kathetervorrichtung zur peritonealen Injektion
US4676782A (en) 1984-09-21 1987-06-30 Vitaphore Corporation Positionable tissue interfacing device for the management of percutaneous conduits
US4959054A (en) * 1988-11-23 1990-09-25 Clemson University Pharmaceutically protected percutaneous devices
US5728102A (en) 1992-09-30 1998-03-17 Staar Surgical Company, Inc. Disposable intraocular lens insertion system
US5728103A (en) 1996-08-23 1998-03-17 Applied Medical Technology, Inc. Implantable subcutaneous access device and method of using same
DE20012624U1 (de) * 2000-07-21 2000-10-19 Storz Karl Gmbh & Co Kg Flexible Trokarhülse

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917686A (en) * 1985-12-16 1990-04-17 Colorado Biomedical, Inc. Antimicrobial device and method
SE455666B (sv) * 1986-04-18 1988-08-01 Dan Lundgren Hudgenomgang
US4915694A (en) * 1987-10-02 1990-04-10 Vitaphore Corporation Antimicrobial wound dressing and skin fixator for percutaneous conduits
JPH02246986A (ja) * 1989-03-20 1990-10-02 Olympus Optical Co Ltd 生体内案内具
US5766249A (en) * 1990-11-20 1998-06-16 Griffith; Donald P. Tissue bondable cystostomy tube and method of cystostomy tube implantation
US5234408A (en) * 1990-11-20 1993-08-10 Griffith Donald P Tissue bondable cystostomy tube and method of cystostomy tube implantation
GR930100244A (el) * 1992-06-30 1994-02-28 Ethicon Inc Εύκαμπτο ενδοσκοπικό χειρουργικό στόμιο εισόδου.
DE4236210C1 (de) * 1992-10-27 1994-04-14 Olympus Optical Europ Schlauchförmiges Implantat zur Verwendung bei der perkutanen Nahrungszufuhr
US5833666A (en) * 1993-11-23 1998-11-10 Uresil Corporation Catheter fixation assembly
US5820607A (en) * 1995-06-05 1998-10-13 Board Of Regents, University Of Texas Systems Multipurpose anti-microbial silastic sheath system for the prevention of device-related infections
US5882341A (en) * 1995-07-07 1999-03-16 Bousquet; Gerald G. Method of providing a long-lived window through the skin to subcutaneous tissue
WO1998058691A1 (en) * 1997-06-25 1998-12-30 Biotap A/S Intercutaneous implant device
US6306114B1 (en) * 1998-06-16 2001-10-23 Eagle Vision, Inc. Valved canalicular plug for lacrimal duct occlusion

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0134340A1 (de) * 1983-08-22 1985-03-20 The University of Utah Research Foundation Kathetervorrichtung zur peritonealen Injektion
US4676782A (en) 1984-09-21 1987-06-30 Vitaphore Corporation Positionable tissue interfacing device for the management of percutaneous conduits
US4959054A (en) * 1988-11-23 1990-09-25 Clemson University Pharmaceutically protected percutaneous devices
US5728102A (en) 1992-09-30 1998-03-17 Staar Surgical Company, Inc. Disposable intraocular lens insertion system
US5728103A (en) 1996-08-23 1998-03-17 Applied Medical Technology, Inc. Implantable subcutaneous access device and method of using same
DE20012624U1 (de) * 2000-07-21 2000-10-19 Storz Karl Gmbh & Co Kg Flexible Trokarhülse

Also Published As

Publication number Publication date
US20040243064A1 (en) 2004-12-02
ES2394646T3 (es) 2013-02-04
DE602004004834D1 (de) 2007-04-05
EP1481697A1 (de) 2004-12-01
US7331940B2 (en) 2008-02-19
ES2282807T3 (es) 2007-10-16
EP1731182B1 (de) 2012-09-26
ATE354384T1 (de) 2007-03-15
US20050203486A1 (en) 2005-09-15
JP4767503B2 (ja) 2011-09-07
DE602004004834T2 (de) 2007-11-08
EP1481697B8 (de) 2008-07-16
US6916310B2 (en) 2005-07-12
JP2004358247A (ja) 2004-12-24
EP1481697B1 (de) 2007-02-21

Similar Documents

Publication Publication Date Title
EP1481697B1 (de) Perkutane Zugangsvorrichtung
CA1245931A (en) Positionable tissue interfacing device for the management of percutaneous conduits
EP0559745B1 (de) Auf gewebe fixierbares cystotomieröhrchen
US6913589B2 (en) Multi-catheter insertion device and method
US7452354B2 (en) Implantable pump connector for catheter attachment
US7270650B2 (en) Catheter anchor system and method
JP4371657B2 (ja) 内方成長を阻止する留置カテーテル組立体
CA2730733C (en) Modular implantable medical device
US5098411A (en) Closed end hollow stylet assembly
US20090131919A1 (en) Implantable medical device
JPS6072565A (ja) 非経口的過栄養カテーテルシステム
JPH11504233A (ja) 生体保持性フィルタ付き注入カテーテル
AU2016266030B2 (en) Catheter having reinforcing rings and method of use
WO2021034807A1 (en) Antimicrobial body access system
AU2013263840A1 (en) Catheter having reinforcing rings and method of use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AC Divisional application: reference to earlier application

Ref document number: 1481697

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

17P Request for examination filed

Effective date: 20070529

17Q First examination report despatched

Effective date: 20070702

AKX Designation fees paid

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602004039502

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: A61M0001000000

Ipc: A61M0039020000

RIC1 Information provided on ipc code assigned before grant

Ipc: A61M 39/02 20060101AFI20120126BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AC Divisional application: reference to earlier application

Ref document number: 1481697

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: E. BLUM & CO. AG PATENT- UND MARKENANWAELTE VSP

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 576728

Country of ref document: AT

Kind code of ref document: T

Effective date: 20121015

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602004039502

Country of ref document: DE

Effective date: 20121122

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2394646

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20130204

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 576728

Country of ref document: AT

Kind code of ref document: T

Effective date: 20120926

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20120926

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20121227

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130128

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20121226

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20130627

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602004039502

Country of ref document: DE

Effective date: 20130627

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130528

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130528

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20040528

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 13

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 14

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20180329

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20180516

Year of fee payment: 15

Ref country code: ES

Payment date: 20180601

Year of fee payment: 15

Ref country code: DE

Payment date: 20180515

Year of fee payment: 15

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20180712 AND 20180718

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20180719 AND 20180725

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20180411

Year of fee payment: 15

Ref country code: IT

Payment date: 20180522

Year of fee payment: 15

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 602004039502

Country of ref document: DE

Representative=s name: MUELLER-BORE & PARTNER PATENTANWAELTE PARTG MB, DE

Ref country code: DE

Ref legal event code: R081

Ref document number: 602004039502

Country of ref document: DE

Owner name: INTEGRA LIFESCIENCES SWITZERLAND SARL, CH

Free format text: FORMER OWNER: CODMAN & SHURTLEFF, INC., RAYNHAM, MASS., US

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20180511

Year of fee payment: 15

REG Reference to a national code

Ref country code: CH

Ref legal event code: PUE

Owner name: DEPUY SYNTHES PRODUCTS, INC., US

Free format text: FORMER OWNER: DEPUY SPINE, LLC, US

Ref country code: CH

Ref legal event code: PUE

Owner name: INTEGRA LIFESCIENCES SWITZERLAND SARL, CH

Free format text: FORMER OWNER: DEPUY SYNTHES PRODUCTS, INC., US

Ref country code: CH

Ref legal event code: PUE

Owner name: DEPUY SPINE, LLC, US

Free format text: FORMER OWNER: CODMAN AND SHURTLEFF INC., US

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602004039502

Country of ref document: DE

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: ES

Ref legal event code: PC2A

Owner name: INTEGRA LIFESCIENCES SWITZERLAND SARL

Effective date: 20200102

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20190528

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190529

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190531

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190528

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20191203

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190528

REG Reference to a national code

Ref country code: SE

Ref legal event code: EUG

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190531

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20200930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190529